0001179110-20-002899.txt : 20200303 0001179110-20-002899.hdr.sgml : 20200303 20200303172018 ACCESSION NUMBER: 0001179110-20-002899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200228 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ginascol John F CENTRAL INDEX KEY: 0001778075 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 20683844 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2020-02-28 0 0000001800 ABBOTT LABORATORIES ABT 0001778075 Ginascol John F 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 0 1 0 0 Executive Vice President Common shares without par value 2020-02-28 4 F 0 2246 79.19 D 73051 D Common shares without par value 2020-03-02 4 S 0 1006 77.89 D 72045 D Common shares without par value 2020-03-02 4 S 0 5600 77.58 D 66445 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.56 to $77.599, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Jessica H. Paik, by power of attorney for John F. Ginascol 2020-03-03